While a shortage of the chemotherapy drugs cisplatin and carboplatin has improved in the United States, some of the nation's largest cancer centers now report additional concerns related to drug shortages, a new report finds.
In Hendricks' practice in Maryland, she said that the center is currently experiencing a significant shortage of the chemotherapy drug etoposide, which was named in the new NCCN report. She added that the center received an alert Tuesday about the shortage.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: